Clinical Trial Update: Proof of Concept Study of OC000459 in Eosinophilic Esophagitis [Phase 2]

View source ↗

Summary

Phase 2 proof-of-concept study of OC000459 in eosinophilic esophagitis has completed.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Eosinophilic Esophagitis

Drugs mentioned

• OC000459

Snippet

Sponsor: Oxagen Ltd | Conditions: Eosinophilic Esophagitis | Phase 2 | Status: COMPLETED